Jump to content

Choose locationChoose Location
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
  • Locations
  • Sign in or Enroll
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Monkeypox Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Research
  • Investigators
  • Raphael Merriman
Content

Investigator Raphael Merriman, MD

Raphael Merriman, MD

View profile  

 


Sutter Health Research Enterprise
2340 Clay Street
San Francisco, CA, 94115
(415) 600-1020  
ClinicalResearch@sutterhealth.org

Primary Research Interests

  • Liver Diseases and Transplant
  • Nonalcoholic Steatohepatitis (NASH)
  • Primary Biliary Cholangitis (PBC)
  • Primary Sclerosing Cholangitis (PSC)

Related Clinical Trials

ASSURE

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

Eiger Hepatitis D Study

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

Investigators: Stewart Cooper M.D., Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

ELATIVE

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)

Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

InFUSE

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Investigators: Todd Frederick M.D., Edward Holt MD, Raphael Merriman MD

Status: Active, Recruiting

MIRUM

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) (VIST

Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

NATIV3

A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibros

Investigator: Raphael Merriman MD

Status: Active, Recruiting

RESPONSE

RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA

Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

About Sutter

  • About Our Network
  • Annual Report
  • Awards
  • Community Benefit
  • Contact Us
  • News
  • Giving
  • Find Care

  • Birth Centers
  • Care Centers
  • Emergency Rooms
  • Hospitals
  • Imaging
  • Labs
  • Surgery Centers
  • Urgent Care
  • Walk-In Care
  • View All >
  • Featured Services

  • Behavioral Health
  • Cancer Services
  • Family Medicine
  • Home Health and Hospice
  • Orthopedics
  • Pediatrics
  • Pregnancy
  • Primary Care
  • Women's Health
  • View All >
  • Patient Resources

  • Accepted Health Plans
  • Classes and Events
  • Estimate Costs
  • Health and Wellness
  • Medical Records
  • Medicare Advantage
  • My Health Online
  • Pay a Bill
  • Symptom Checker
  • Our Team

  • For Employees
  • Physician Careers
  • Recruiting Events
  • Residencies and Fellowships
  • Sutter Careers
  • Vendors
  • Volunteers
    • ADA Accessibility
    • Contact
    • Privacy
    • Do Not Sell My Personal Information

    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Glassdoor Opens new window
    • Instagram Opens new window

    Copyright © 2022 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

    Cookie Policy

    We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

    Privacy Policy Cookie Preferences